Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On April 21, 2023, Unique Fabricating, Inc. (the "Company") received a notice letter (the "Notice") from the NYSE Regulation Department (the "Staff") notifying the Company that it was not in compliance with the continued listing standard set forth in Part 10 of the New York Stock Exchange American ("NYSE American" or the "Exchange") Company Guide (the "Company Guide") because the Company's common stock has a 30 trading-day average closing price of less than $0.20 per share of common stock. The Company is now subject to the procedures and requirements set forth in Section 1009 of the Company Guide.

The Company plans to notify the Exchange that it intends to submit a plan to cure this deficiency and return to compliance with the NYSE American continued listing requirements. In order to avoid delisting under Section 1009(c), the Company has 30 days from the receipt of the Notice to submit a plan advising the Exchange of definitive actions the Company has taken, or proposes to take, that would bring it into compliance with the continued listing standards on or before October 21, 2023 (the "Cure Period"). If the Exchange accepts the plan, the Company's common stock will continue to be listed and traded on the NYSE American during the Cure Period, subject to the Company's compliance with other continued listing standards, and the Company will be subject to quarterly monitoring by the Staff for compliance with the plan. There is no assurance that the Company will be able to timely develop or submit a plan or that the Company will be able to implement any plan. The Exchange can take accelerated delisting action at anytime if the Company's common stock trades at levels viewed to be abnormally low.

The Exchange also informed the Company that the Company's common stock at this time will continue to trade under the symbol "UFAB," but will have an added designation of ".BC" to indicate that the Company is not currently in compliance with NYSE American continued listing standards.

Item 9.01. Exhibits.

(d) Exhibits. The following exhibits are filed herewith:

© Edgar Online, source Glimpses